Denali Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.14B
Liabilities Breakdown FY2025
Total Liabilities: $131.1M
Asset Breakdown
Total Assets: $1.14B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $205.3M | 17.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $52.4M | 4.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $887.1M | 77.5% |
Liabilities Breakdown
Total Liabilities: $131.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.3M | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $127.8M | 97.5% |